Researchers at the Weizmann Institute of Science have identified a protein, MTCH2, that acts as a cellular switch regulating fat storage and burning, with its absence causing cells to drastically increase fat and sugar consumption while severely inhibiting the formation of new fat cells. Experiments involving the deletion of the MTCH2 gene in lab-grown cells revealed a hyperactive metabolic state, characterized by rapid fuel utilization and increased oxygen consumption by mitochondria, and in preadipocytes, a dramatic reduction in their maturation into fat cells. This discovery, published in The EMBO Journal, suggests MTCH2's critical role in balancing cellular energy expenditure and storage, potentially offering a novel target for obesity treatment, although this research is currently limited to lab settings and further investigation is required before any clinical applications can be considered.

Researchers at the Weizmann Institute of Science have identified a protein, MTCH2, that acts as a cellular switch regulating fat storage and burning, with its absence causing cells to drastically increase fat and sugar consumption while severely inhibiting the formation of new fat cells. Experiments involving the deletion of the MTCH2 gene in lab-grown cells revealed a hyperactive metabolic state, characterized by rapid fuel utilization and increased oxygen consumption by mitochondria, and in preadipocytes, a dramatic reduction in their maturation into fat cells. This discovery, published in The EMBO Journal, suggests MTCH2's critical role in balancing cellular energy expenditure and storage, potentially offering a novel target for obesity treatment, although this research is currently limited to lab settings and further investigation is required before any clinical applications can be considered.

Researchers at the Weizmann Institute of Science have identified a protein, MTCH2, that acts as a cellular switch regulating fat storage and burning, with its absence causing cells to drastically increase fat and sugar consumption while severely inhibiting the formation of new fat cells. Experiments involving the deletion of the MTCH2 gene in lab-grown cells revealed a hyperactive metabolic state, characterized by rapid fuel utilization and increased oxygen consumption by mitochondria, and in preadipocytes, a dramatic reduction in their maturation into fat cells. This discovery, published in The EMBO Journal, suggests MTCH2's critical role in balancing cellular energy expenditure and storage, potentially offering a novel target for obesity treatment, although this research is currently limited to lab settings and further investigation is required before any clinical applications can be considered.

Imagine a switch inside every cell in your body that decides: burn this fat now, or save it for later. Scientists just found it and flipping it off seems to turn cells into fat-burning machines that also lose the ability to make new fat cells in the first place. 

The discovery comes from researchers at the Weizmann Institute of Science in Israel, published in The EMBO Journal in early 2025. It could change the way scientists think about fighting obesity, not from the outside, but from deep inside individual cells. 

The fat-resistant mice

Mice missing this protein, called MTCH2, in their muscles ate completely normal amounts of food. But here's the twist: even on a high-fat diet, they didn’t put on fat. This new study explains why. 

What happens when you remove the switch?

Researchers deleted the MTCH2 gene from human cells in the lab and watched closely for hours, tracking hundreds of molecules the cells use for fuel and building blocks. 

The result? The cells acted like they were starving, even though they weren't. They burned through sugar, fat, and protein much faster than normal. Their energy currency got used up so quickly that the cells had to scramble to keep making more. 

Oxygen use, a sign of how hard the cell's internal power plants (mitochondria) are working, shot up too, both at rest and under stress. The mitochondria were in overdrive, torching fuel just to keep the lights on.

A weird fat puzzle 

Things got strange when researchers looked at where fat was actually stored. Fat in the cell membranes dropped, while stored fat reserves grew and the number of fat droplets increased over time. 

That might sound like the opposite of 'burning fat', but it wasn't. The cells were actually breaking down fat and stashing the leftover pieces away as a coping mechanism, not gaining fat. 

New fat cells almost stopped forming

Here's the most jaw-dropping part. Scientists used lab cells called preadipocytes, baby cells that normally grow into full, mature fat cells within about six days. 

In normal conditions, 80 to 90 out of 100 of these cells successfully matured into fat cells. Without MTCH2? Only 5 to 10 out of 100 made it. Almost none of them became real fat cells. 

It all comes down to energy

Turning a baby cell into a mature fat cell is a slow, careful building process.  It needs a steady, calm supply of energy. But cells without MTCH2 were stuck in 'panic mode', racing to burn through fuel instead of settling down to build. The genetic instructions needed to kick off fat cell formation simply never switched on.

Scientists also noticed the cells' mitochondria, their power plants, broke apart into small fragments instead of forming their usual connected networks, a pattern seen in other fat-related studies too. 

So what does this mean?

Putting it all together, the researchers believe MTCH2 acts like a master control switch - balancing how much energy a cell burns versus how much it saves up to grow. Take away the switch, and the cell tips hard toward burning fuel instead of building fat stores. 

As the researchers put it, "these results underscore MTCH2's role as a crucial regulator of cellular energy flow." 

Don't get too excited yet

Before anyone starts dreaming of a fat-burning pill, a big reality check: this was all done in lab-grown cells, not in living animals or humans. The fat cell experiments also relied on a mouse cell line, not actual human tissue.

Earlier research had already shown that mice lacking this protein in their muscles resisted weight gain on fatty diets; this new study just digs into the cellular "why" behind that resistance. 

Most weight-loss drugs on the market today work by suppressing appetite. Scientists have long searched for a different approach, one that pushes the body to naturally burn more energy and store less fat. MTCH2, a gene already linked to obesity risk in large human studies, might be a piece of that puzzle. Whether it could ever be turned into a real treatment for people is still an open question.

This story is done in collaboration with First Check, which is the health journalism vertical of DataLEADS

TAGS